StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Gone for 2 weeks

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Apr 30, 2021 10:39am

100 Views

Post# 33100819

RE:RE:Gone for 2 weeks

Liked2think: This is a side play for me, I bought 80% pre-RS so I don't feel the searing pain you do.

I am extremely annoyed at Stage for the mickey mouse rollout of aristotle and the CC.

The state of the current stock price is friendly fire, entirely self-inflicted by Stage management.

I would like to see one simple line on a financial sheet that shows:
colonsentry revenues: $$$$$.$$
aristotle revenues: $$$$$.$$

But no, heaven forbid some real dsiclosure.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December